Vaccines

The UK HVC has acquired or manufactured a number of homologous HIV vaccines for use in early phase I trials in humans.

Adjuvant

The UK HVC has partnered with a non-profit organisation to access a potent adjuvant for use with its GP140 protein immunogen.

Trial Management

The UK HVC also provides clinical trial management support to Phase I studies through Imperial fully registered Clinical Trial Unit.
Email
Print
WP Socializer Aakash Web